An Open-label Extension Study to Investigate the Long term Safety, Tolerability, Pharmacokinetics, and Efficacy of WVE N531 in Patients with Duchenne Muscular Dystrophy Who Participated in Another Study of WVE N531 (WVE-N531-002)

Principal Investigator

Prof Laurent Servais

Contact us

Email: childrensresearch@ouh.nhs.uk

IRAS number

1012841